GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amgen Inc. (AMGN) [hlAlert]

Rating:
Overweight
AMGN
up 36.16 %

Amgen Inc. (AMGN) rated Overweight by Piper Jaffray

Posted on: Wednesday,  Nov 27, 2013  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Amgen Inc. (NASDAQ: AMGN) on 11/27/2013, when the stock price was $114.36. Since
then, Amgen Inc. has gained 36.17% as of 08/27/2015's recent price of $155.72.
If you would have followed this Piper Jaffray's recommendation on AMGN, you would have gained 36.16% of your investment in 638 days.

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/27/2013 8:25 AM Buy
None
114.36
as of 12/13/2013
1 Week down  -1.71 %
1 Month down  -1.20 %
3 Months down  -2.52 %
1 YTD up  23.52 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/26/2013 8:25 AM Buy
None
111.44
4/24/2013 8:25 AM Hold
None
108.13
7/27/2012 8:25 AM Buy
None
82.36
3/12/2010 8:25 AM Hold
None
57.66

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy